Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 173,971 |
|
|||||
| News | - | ||||||
| Day High | 0.8199 | Low High |
|||||
| Day Low | 0.7752 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AlloVir Inc | ALVR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0309 | -3.78% | 0.7855 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8199 | 0.7752 | 0.8199 | 0.7855 | 0.8164 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,936 | 173,971 | $ 0.8006886 | $ 139,297 | - | 0.6231 - 6.12 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:38:05 | 2 | $ 0.7761 | USD |
AlloVir Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 90.11M | 114.06M | - | 0 | -190.42M | -1.67 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AlloVir News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALVR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.81 | 0.82 | 0.7752 | 0.7978942 | 190,693 | -0.0245 | -3.02% |
| 1 Month | 0.7579 | 0.825 | 0.72 | 0.7747434 | 281,163 | 0.0276 | 3.64% |
| 3 Months | 0.68 | 0.85 | 0.6685 | 0.7540665 | 480,198 | 0.1055 | 15.51% |
| 6 Months | 1.40 | 2.485 | 0.6231 | 0.9134982 | 1,366,848 | -0.6145 | -43.89% |
| 1 Year | 4.44 | 6.12 | 0.6231 | 1.63 | 1,058,047 | -3.65 | -82.31% |
| 3 Years | 23.75 | 26.41 | 0.6231 | 4.84 | 673,670 | -22.96 | -96.69% |
| 5 Years | 22.82 | 48.96 | 0.6231 | 7.88 | 604,374 | -22.03 | -96.56% |
AlloVir Description
| AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. |
